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Purpose: To date, more than thirty nine genetic loci have been associated with congenital cataracts. Despite this progress,
current diagnostic techniques are insufficient for unraveling the underlying genetic defect in sporadic patients and small
families. In the present manuscript we demonstrate the contribution of routine laboratory tests in the search for genetic
defects of childhood cataracts.
Methods: Two families with congenital cataracts and hematologic findings that included hyperferritinemia and the “ii”
blood type underwent detailed ophthalmologic and clinical examinations. Mutation analysis of the ferritin light chain
(FTL) and glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (GCNT2) genes was performed in the two families,
respectively.
Results: In the family with the “ii” blood group we found a novel GCNT2 mutation c.G935A (p.G312D) in the cataract
patients, while in the family with hyperferritinemia cataract syndrome we identified a G→C heterozygous mutation at
position +32 of FTL.
Conclusions: Hematologic biomarkers may simplify the search for the underlying molecular defect in families with
congenital cataract.
Congenital cataract encompasses many different diseases
with distinct causes and diverse biologic pathways that result
in  crystalline  lens  opacities.  While  senile  cataract  is
considered  a  common  treatable  disorder  of  the  elderly,
congenital cataract is particularly serious because it has the
potential of inhibiting visual development, and may result in
permanent blindness. The frequency of congenital cataract is
estimated at 1–6 per 10,000 live births, and up to one third of
them are inherited [1]. They vary markedly in severity and
morphology,  affecting  the  nuclear,  cortical,  polar  or
subcapsular parts of the lens, or in severe cases the entire lens
[2]. The phenotype by itself is not a good predictor of the
underlying  gene  or  mutation  since  identical  cataracts  can
result from mutations at different genetic loci, and may have
different  inheritance  patterns.  Contrarily,  various  cataract
types  can  be  found  in  a  single  large  family  [3].  Usually,
congenital cataracts occur in an isolated fashion affecting the
lens alone or in conjugation with other ocular anomalies such
as microphthalmia, aniridia, and retinal degenerations. They
may  also  be  associated  with  myriad  systemic  conditions
including  chromosomal  abnormalities;  craniofacial,
mandibulofacial,  and  skeletal  syndromes;  metabolic
disorders;  congenital  infections;  dermatologic,  central
nervous system (CNS), musculoskeletal, or renal disease [4].
More than 39 genetic loci for cataract have been mapped, and
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in more than twenty-five of them specific genes have been
identified (Cat-Map). These tools have been very successful
in  determining  the  underlying  genetic  defect  in  large
pedigrees  and  in  sporadic  patients  whenever  cataract
manifests as one component of a multisystem syndrome as in
Lowe syndrome or neurofibromatosis type-2 [3-5]. However,
in sporadic patients and small families with non-syndromic
congenital  cataract  it  is  almost  an  impossible  task.
Nevertheless,  there  are  instances  where  the  distinction
between syndromic cataracts and isolated ones is less evident,
and  congenital  cataracts  are  accompanied  by  occult
abnormalities in other organs.
In the present study we describe two small families of
congenital cataract and abnormal blood tests which suggested
their  underlying  pathology.  In  one  of  the  families  the
association of high serum ferritin levels with cataract guided
us to search for mutations in the ferritin light chain (FTL) gene,
while the finding of “ii” blood type in affected members of
the second cataract family lead us to look for mutations in the
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme
(GCNT2) gene.
METHODS
The  study  protocol  adhered  to  the  provisions  of  the
Declaration of Helsinki and informed consent was obtained
from the participants. The two families were recruited at the
Genetic Eye Clinic, Assaf Harofeh Medical Center, Zerifin,
Israel (Figure 1A,D). Family members underwent a detailed
ophthalmologic  examination,  which  included  slit  lamp
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1011biomicroscopy with photography of the cataract lenses (when
possible). Heparinized blood was obtained for genomic DNA
isolation, blood typing, serum ferritin and iron levels, and total
iron binding capacity.
I/i  blood  group  and  serum  ferritin  level  testings:  I/i
phenotype was tested at the Israeli National Blood Group
Reference  Laboratory  (NBGRL)  at  Magen  David  Adom
Blood  Services  in  Israel.  Testing  was  performed  by
conventional (tube) methods [6], using anti-I and anti-i from
Serum Cells and Rare Fluids (SCARF) and anti-i from our in-
house anti-sera collection. Cord red blood cells were used as
a positive control for i and negative control for I. Adult red
blood cells were the positive control for I and negative control
for  i.  Serum  ferritin  levels  were  determined  with  the
electrochemiluminesence  immunoassay  “ECLIA”method
(Elecsys and cobas e analyzers) [7].
FTL  and  GCNT2  mutation  screening:  The  Iron
Responsive element (IRE) at the 5-'UTR region of FTL and
all exons and exon-intron boundaries of the GNTC2 gene were
amplified from genomic DNA using specific primer pairs
(Table  1),  and  sequenced  with  BigDye  Terminator  cycle
sequence kit v3.1 (Applied Biosystems, Inc. ABI, Foster City,
CA) according to manufacturer's instructions. One hundred
chromosomes of Ashkenazi Jewish and Persian Jewish origins
without any known ocular diseases were used as controls.
RESULTS
Family 1: This is a relatively small three generation Ashkenazi
Jewish family emigrated from Romania to Israel 40 years ago
Figure 1. Clinical features and genetic analysis. A: Ashkenazi Jewish family pedigree affected by Hereditary Hyperferritinemia Cataract
Syndrome. B: Slit-lamp retroilluminative view of the lens discloses nuclear cataract with prominent Y sutures. C: DNA sequence analysis of
the IRE (iron responsive element) part of FTL (ferritin light chain). A heterozygous G→C change in the 5`-untranslated region (5`-UTR) at
position +32 from transcription start site (c. −168G→C), is indicated by black arrow. D: Persian Jewish family pedigree affected by congenital
cataract (no photograph available) and phenotype ii. E: DNA sequence analysis showing a homozygous G → A transition (indicated by black
arrow) at cDNA position 935, resulting in a change of Glycine to Aspartic acid (p.G312D) of all three isoforms of GCNT2.
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1012(Figure 1A). The index case (individual 05), a six-year-old
child  was  diagnosed  as  having  bilateral  nuclear  cataracts
(Figure 1B), with visual acuity of 6/12 in both eyes. A detailed
ophthalmologic  examination  performed  on  his  eighteen
months  old  brother  (individual  06)  revealed  mild  sutural
cataract.  Slit-lamp  biomicroscopy  demonstrated  a  nuclear
cataract with prominent Y sutures in both children. After
discussing the option of surgical treatment with the parents a
decision for conservative follow-up was made.
The family history revealed that the mother (individual
03) had visual disturbances since childhood and underwent
cataract extraction at the age of 41. The maternal grandfather
(individual 01) had bilateral decreased vision since childhood
and had cataract surgery at the age of 40.
Since cataract extraction, both the mother (individual 03)
and  her  father  (individual  01)  were  both  pseudophakic.
Otherwise no other ophthalmic pathology was found. At the
age of 45, as an incidental finding individual 03 was found to
have elevated ferritin levels in the absence of iron overload,
ranging between 1,393 and 1,621 ng/ml (normal: 20–167 ng/
ml). Serum ferritin level in individual 05 was 1,161 ng/ml, and
1,300 ng/ml in individual 01.
The tenfold increase in L-ferritin levels in association
with  early  onset  nuclear  cataract  was  consistent  with  the
diagnosis of Hereditary Hyperferritinemia Cataract Syndrome
(HHCS; OMIM 600886). Sequencing FTL in the 4 affected
family members (individuals 01, 03, 05, and 06) showed a
heterozygous change G→C (Figure 1C) at position 32 from
the  transcription  start  site  (c.  −168G→C).  This  sequence
variation  occurred  in  the  iron  responsive  element  (IRE)
located at the 5′-UTR of FTL. The change was not seen in the
unaffected family members (individuals 04 and 02) nor was
it found in 200 ethnically matched control chromosomes.
Family 2: The index patient (individual 07) a daughter of first
cousin parents of Persian Jewish decent was noticed to suffer
from  congenital  cataract  soon  after  birth.  Family  history
revealed  a  great  maternal  aunt  (individual  03),  born  to
consanguineous  parents,  who  also  had  congenital  cataract
(Figure 1D). By history both had bilateral leukocoria (white
pupil) evident during early infancy and opaque lenses that
prevented ophthalmoscope retinal examination before lens
extraction. Ophthalmic examination of the index case and her
great aunt (individuals 07 and 03) revealed bilateral blindness
with very low visual acuities ranging from hand motions to
counting fingers before eyes. Both had nystagmous, severe
amblyopia, and aphakia. No pathology or photography of the
lens was available. No ocular abnormalities were found in the
parents and unaffected sibling. Blood typing performed on the
index  case  (individual  07)  before  gynecological  surgery
revealed that she was homozygous for the ii blood group. Her
great aunt (individual 03) was found to have the same ii blood
group.  Sequencing  the  three  different  GCNT2  isoforms
revealed a homozygous G→A substitution at position 935 of
the cDNA (c.G935A), resulting in a change of an evolutionary
conserved Glycine to Aspartic acid (p.G312D) in all three
isoforms, GCNT2A, -B, and -C (Figure 1E). This change was
not detected in 200 Persian Jewish control chromosomes.
DISCUSSION
The discovery of a broad variety of genes associate with
congenital  cataracts  hurdles  the  search  for  the  underlying
causative mutation especially in sporadic patients and families
too small for linkage studies. In the present study unraveling
the underlying mutations in two congenital cataract families
was relatively simple thanks to associated blood findings that
focused the search to a single gene.
The  first  family  was  diagnosed  with  Hereditary
Hyperferritinemia Cataract Syndrome (HHCS) due to a single
nucleotide change (c. −168G→C) in the IRE of L-Ferritin
mRNA, identified in the heterozygous state in all affected
members. This substitution occurs in the highly conserved
three-nucleotide  bulge  structure  (positions  31–33)  of  FTL
promoter (IRE) that is considered a mutation “hot-spot,” and
many  of  the  HHCS  families  described  to  this  date  carry
mutations  at  the  same  nucleotide  position  (32G→U  and
32G→A)  [8-12].  This  position  32G  has  been  previously
demonstrated to have a pivotal role in the regulation of FTL
mRNA [13,14], resulting in upregulation of L-ferritin in the
TABLE 1. PRIMERS FOR PCR AMPLIFICATION OF GCNT2, AND THE IRON RESPONSIVE ELEMENT (IRE) OF THE FTL GENE.
Gene Annealing
temperature
Fw primer Rv primer Product size
(bp)
GCNT2 exon1A 60 ºC 5’-TGTAGACACAGGTTGCAGGTTAGCA-3’ 5’- GCAGGTAGCTTCATCAAGGGTA -3’ 222 bp
55 ºC 5’-TAGCAGAAGCCTGTCATCAG-3’ 5’- CCTTCAGATACTGAACTATTTC -3’ 491 bp
55 ºC 5’-AACACCTGCGGGCAAGACTT-3’ 5’-CTTTTGTCCTGTGAACAGAGCGGTT-3’ 570 bp
GCNT2 exon1B 55 ºC 5’-AGACTTACAGATTTTGACGGT-3’ 5’-TAGATATTTTGGGGCATGTA-3’ 414 bp
57 ºC 5’-CCATCATCACTTTGACACCT-3’ 5’-CTTATCACATAGGAAAGCTCT-3’ 429 bp
55 ºC 5’-CTCATGCAATTGGACGGACT-3’ 5’-GGGTGAGAACTATATATGTTCCAGTT-3’ 380 bp
GCNT2 exon1C 55 ºC 5’-GCAAATTCAACCTCTCACACCGATC-3’ 5’-GGGGCATATAGATAGCCCTAA-3’ 437 bp
55 ºC 5’-TGTCATGGTCATCCATAAGG-3’ 5’-CTTGGTGGACATATTTAGTT-3’ 407 bp
55 ºC 5’-AGGATTTAAAGGGAAAAATATC-3’ 5’-TGAGTCAGTTCTCTAGGCGAGCAG-3’ 374 bp
GCNT2 exon2 57 ºC 5’-CTGAAGTGGAGAAACCCTGGCTTA-3’ 5’-AACCCTGGATTCCACAGCTACCTT-3’ 514 bp
GCNT2 exon3 55 ºC 5’-AGTTGTAGTTAGTCGGAGAGTACCT-3’ 5’-TATAATTACGTAGCCAGGTCCTGAA-3’ 430 bp
IRE of FTL 58 °C 5’-GGCTGTTAGTGCTCCCATAA-3’ 5’-GATCTGTTCCGTCCAAACAC-3’ 383 bp
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were examined at birth under the neonatal screening protocol
implemented in Israel, which includes examination of the
retinal red reflex. Both were found normal, supporting the
hypothesis that the cataract in HHCS is not congenital, but
develops later in life. These findings are in line with previous
reports that some children with high serum ferritin levels and
the same mutation as their affected relatives with cataract did
not have cataract. Francesca et al. have suggested that the
opacities  may  be  the  outcome  of  age-related  ferritin
accumulation  in  the  lens  [17].  Interestingly,  we  did  find
opacities in an 18 months old child from this family, one of
the youngest patients described with HHCS cataract. Thus it
is evident that other factors, environmental or genetic play a
role in the timing of HHCS cataract development.
The  second  family  of  Persian  Jewish  origin  had  a
different  underlying  disorder.  Two  members  of  this
consanguineous family were found homozygotes for a novel
mutation  in  GCNT2.  This  gene  encodes  for  a  specific
transferase,  I-branching  β-1,6-N-
acetylglucoseaminyltransferase  (I  β  6GlcNAcT)  which  is
essential for the conversion of i into I antigenic structure on
various cell types. Previous studies of the human I locus,
located  on  chromosome  6p,  revealed  that  GCNT2  has  3
splicing variants, A, B, and C, which differ at exon 1 but have
identical exon 2 and 3 coding regions, and are expressed
differentially in specific tissues. Mutation events that occur in
the specific exon 1 region of GCNT2 may lead to a defect in
one isoform of the GCNT2 enzyme and i phenotype in certain
cell types, whereas those that occur in the common exon 2 to
3 region result in i phenotype as well as congenital cataract,
due to the elimination of the activity of all three isoforms of
the GCNT2 enzyme [18]. In agreement with the above, the
mutation found in our family occurs in the second exon and
therefore results in the i blood type as well as congenital
cataract.
The two families described in this report highlight the
need to rule out for systemic disorders before embarking a
molecular search for mutations. Other examples where early
onset cataract is the major manifestation of an underlying
systemic  disorder  include  renal  glucosuria  due  to  solute
carrier  family  16,  member  12  (monocarboxylic  acid
transporter  12;  SLC16A12)  mutations  [19],  and  lactose
intolerance due to galactokinase 1 (GALK1) mutations [20].
We therefore propose to check blood glucose and ferritin
levels, urine glucose and the i/I blood-type, as the first step of
evaluation in such cases.
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